Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters|April 18, 2012
Synthesis and biological evaluation of new potent and selective HCV NS5A inhibitorsJunxing Shi, Longhu Zhou, Franck Amblard, et al.Journal of Medicinal Chemistry|November 4, 2014
Asymmetric binding to NS5A by daclatasvir (BMS-790052) and analogs suggests two novel modes of HCV inhibitionJames H Nettles, Richard A Stanton, Joshua Broyde, et al.Physical Chemistry Chemical Physics : PCCP|October 7, 2021
Understanding charge storage in Nb2CT MXene as an anode material for lithium ion batteriesRenfei Cheng, Tao Hu, Zuohua Wang, et al.Antimicrobial Agents and Chemotherapy|June 1, 2017
Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA PolymeraseMaryam Ehteshami, Longhu Zhou, Sheida Amiralaei, et al.RSC Medicinal Chemistry|January 5, 2026
Prodrug strategies in developing antiviral nucleoside analogsR Rama Suresh, Tuniyazi Abuduani, Mahesh Kasthuri, et al.Antiviral Research|November 27, 2013
Chutes and ladders in hepatitis C nucleoside drug developmentSteven J Coats, Ethel C Garnier-Amblard, Franck Amblard, et al.Science Advances|June 6, 2025
Strategy to overcome a nirmatrelvir resistance mechanism in the SARS-CoV-2 nsp5 proteaseGrace Neilsen, Shuiyun Lan, Ryan L Slack, et al.Antimicrobial Agents and Chemotherapy|May 25, 2016
Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094Maryam Ehteshami, Sijia Tao, Tugba Ozturk, et al.Journal of Medicinal Chemistry|January 18, 2019
Discovery of a Series of 2'-α-Fluoro,2'-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C VirusSeema Mengshetti, Longhu Zhou, Ozkan Sari, et al.Pageof 3